関連する実験動画
Updated: Feb 17, 2026

10:37
Transcranial Direct Current Stimulation tDCS for Memory Enhancement
Published on: September 18, 2021
15.9K
トルコのゲロントロジストのアルツハイマー病に関する知識
İrem Tanriverdi1, İrem Bilgic1, Ozge Pasin2
1Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkiye.
Gerontology & geriatrics education
|February 16, 2026
まとめ
トルコのゲロントロジーの卒業生は,アルツハイマー病 (AD) の知識が適度である. 女性,就職者,自己認識の知識のある卒業生は,より高い得点を得ており,ADのケアと予防に関するターゲットを絞った教育の必要性を示しています.
科学分野:
- ゲロントロジーはゲロントロジーの学科です.
- 神経科学は神経科学である.
- 公衆衛生は公衆衛生である.
背景:
- アルツハイマー病 (AD) は,世界的な健康上の大きな課題となっています.
- ゲロントロジーの卒業生の知識の評価は,効果的なADケアに不可欠です.
- ADの知識に影響を及ぼす要因を理解することで,教育戦略に情報を与えることができます.
研究 の 目的:
- アルツハイマー病 (AD) 知識レベルをトルコのゲロントロジーの卒業生で評価する.
- 認知症の知識に関連した人口統計的および職業的要因を特定する.
- アルツハイマー病の理解における強みと弱さの特定の領域を特定する.
主な方法:
- トルコの100人のゲロントロジーの卒業生を対象とした横断的な研究.
- トルコのアルツハイマー病知識スケール (ADKS-TR) と人口統計に関する質問を用いたオンライン調査.
- マン・ウィトニーUおよびクルスカル・ワリス試験を含む統計分析 (p < .05 重要度).
主要な成果:
- ADの総合的な知識は中程度 (平均ADKS-TRスコア:22.04 ± 3.44).
- 女性,就職者,自己認識の知識のある卒業生で,より高い得点が見られた.
- 症状と診断の強い理解にもかかわらず,ケア,予防,意思決定における知識のギャップが特定されました.
結論:
- トルコのゲロントロジーの卒業生は,ジェンダー,雇用,自己認識の影響を受け,適度なAD知識を示しています.
- ADの介護と予防の実践的な側面における重大な知識の不足に注意が必要です.
- 継続的な実践指向の教育プログラムは,アルツハイマー病のケアにおける専門的な能力を高めるために不可欠です.
関連する概念動画
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Alzheimer's Disease: Treatment
994
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
994
Dementia
584
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
584
Drug Dosing: Geriatric Patients
281
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
281
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
717
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
717
Pharmacodynamics in Geriatric Patients: Effects of Age
242
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
242

